Evidence map›Paper›PMID 32326127›Full record

ArticleViruses2020

Phylodynamics Helps to Evaluate the Impact of an HIV Prevention Intervention.

Tetyana I Vasylyeva, Alexander Zarebski, Pavlo Smyrnov, Leslie D Williams, Ania Korobchuk, Mariia Liulchuk, Viktoriia Zadorozhna, Georgios Nikolopoulos, Dimitrios Paraskevis, John Schneider and 3 more

Abstract read
In one paragraph

Article in Viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Editorial: HIV-1 genetic diversity, volume II.Frontiers in microbiology · 2022
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tetyana I VasylyevaDepartment of Zoology, University of Oxford, OX1 3SY Oxford, UK.
Alexander ZarebskiDepartment of Zoology, University of Oxford, OX1 3SY Oxford, UK.
Pavlo SmyrnovAlliance for Public Health, Kyiv 03150, Ukraine.
Leslie D WilliamsDivision of Community Health Sciences, University of Illinois at Chicago School of Public Health, Chicago, IL 60612, USA.
Ania KorobchukAlliance for Public Health, Kyiv 03150, Ukraine.
Mariia LiulchukState Institution "The L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of NAMS of Ukraine", Kyiv 03038, Ukraine.
Viktoriia ZadorozhnaState Institution "The L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of NAMS of Ukraine", Kyiv 03038, Ukraine.
Georgios NikolopoulosMedical School, University of Cyprus, Nicosia 1678, Cyprus.
Dimitrios ParaskevisDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 157 72 Athens, Greece.
John SchneiderDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
Britt SkaathunDepartment of Medicine, University of California San Diego, San Diego, CA 92093, USA.
Oliver G PybusDepartment of Zoology, University of Oxford, OX1 3SY Oxford, UK.
Samuel R FriedmanDepartment of Population Health, New York University, New York, NY 10003, USA.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Next-Generation Phylodynamics-targeted Partner Service Models for Combined HIV PreventionR01AI136056 · NIAID · UNIVERSITY OF CHICAGO · PI BENBOW, NANETTE DIOR, D'AQUILA, RICHARD · 2018 to 2022
$4.0M
Preventing HIV Transmission by Recently-Infected Drug UsersDP1DA034989 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI FRIEDMAN, SAMUEL R · 2012 to 2016
$3.8M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIDA NIH HHS DP1 DA034989NIH HHS P30 AI036214NIH HHS R01AI136056
6 · The paper itself

Abstract

Assessment of the long-term population-level effects of HIV interventions is an ongoing public health challenge. Following the implementation of a Transmission Reduction Intervention Project (TRIP) in Odessa, Ukraine, in 2013-2016, we obtained HIV

Indexed as

PhylogenyHIV-1HIV InfectionsHumansMolecular Epidemiologypol Gene Products, Human Immunodeficiency VirusViral Loadpol Gene Products, Human Immunodeficiency Virusbirth-death modelHIVinterventionphylodynamicsprevention

Identifiers

PMID32326127
PMCPMC7232463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.